Also trades as: AMBU-B.CO (CPH) · $vol 9M · AMBFF (OTC) · $vol 0M

$10.80

-0.20 (-1.82%)

Weekly Expected Move ±5.5%

$10 $10 $11 $11 $12

OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 57 · $2.9B mcap · 228M float · 0.0002% daily turnover · Short 45% of daily vol

Revenue

$5.7B +5.5% ▲

5Y CAGR: +9.8%

Gross Profit

$3.2B -0.6% ▼

5Y CAGR: +7.5%

Operating Income

$738M +14.5% ▲

5Y CAGR: +11.5%

Net Income

$574M +144.1% ▲

5Y CAGR: +18.9%

EPS (Diluted)

$2.15 +144.3% ▲

5Y CAGR: +17.3%

EBITDA

$1.1B +59.8% ▲

5Y CAGR: +12.7%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$4.0B	$4.4B	$4.8B	$5.4B	$5.7B
YoY Growth	+12.5%	+10.7%	+7.4%	+12.9%	+5.5%
Cost of Revenue	$1.5B	$1.9B	$2.1B	$2.2B	$2.5B
Gross Profit	$2.5B	$2.6B	$2.7B	$3.2B	$3.2B
Gross Margin	62.4%	57.5%	56.8%	59.4%	56.0%
R&D Expenses	$225M	$281M	$295M	$325M	$129M
SG&A Expenses	$1.9B	$2.2B	$2.1B	$2.2B	$2.3B
Operating Expenses	$2.2B	$2.4B	$2.4B	$2.6B	$2.4B
Operating Income	$340M	$144M	$302M	$645M	$738M
Operating Margin	8.5%	3.2%	6.3%	12.0%	13.0%
Interest Expense	$26M	$32M	$86M	$27M	$28M
Income Before Tax	$308M	$109M	$210M	$300M	$711M
Tax Expense	$61M	$16M	$42M	$65M	$138M
Net Income	$247M	$93M	$168M	$235M	$574M
Net Margin	6.2%	2.1%	3.5%	4.4%	10.1%
EPS (Diluted)	$0.98	$0.37	$0.64	$0.88	$2.15
EBITDA	$500M	$492M	$644M	$682M	$1.1B
Shares Outstanding	253M	254M	261M	267M	267M

Line Item	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$1.4B	$1.5B	$1.6B	$1.5B	-$23.4B	$1.6B	$1.6B	$1.7B
Cost of Revenue	$570M	$585M	$612M	$620M	-$9.1B	$611M	$635M	$676M
Gross Profit	$817M	$925M	$942M	$887M	-$14.3B	$947M	$964M	$992M
Gross Margin	58.9%	61.3%	60.6%	58.9%	61.3%	60.8%	60.3%	59.5%
R&D Expenses	$86M	$79M	$88M	$87M	-$1.5B	$93M	$93M	$89M
SG&A Expenses	$584M	$603M	$630M	$630M	-$9.5B	$689M	$684M	$679M
Operating Expenses	$670M	$682M	$718M	$717M	-$11.0B	$783M	$788M	$767M
Operating Income	$147M	$243M	$224M	$170M	$147M	$164M	$176M	$225M
Operating Margin	10.6%	16.1%	14.4%	11.3%	-0.6%	10.5%	11.0%	13.5%
Interest Expense	$0	$10M	$20M	$13M	-$245M	$15M	$19M	$24M
Income Before Tax	-$181M	$237M	$208M	$160M	$106M	$153M	$160M	$207M
Tax Expense	-$46M	$54M	$20M	$37M	$27M	$35M	$37M	$48M
Net Income	-$135M	$183M	$188M	$123M	$115M	$118M	$123M	$159M
Net Margin	-9.7%	12.1%	12.1%	8.2%	-0.5%	7.6%	7.7%	9.5%
EPS (Diluted)	$-0.51	$0.68	$0.71	$0.46	$0.43	$0.44	$0.46	$0.60
EBITDA	-$93M	$335M	$322M	$266M	$247M	$265M	$276M	$327M
Shares Outstanding	266M	269M	265M	267M	267M	268M	267M	267M

AMBBY OTC